Article

Advances in Nanoparticle-Enhanced Vaccine Strategies: Towards a Universal Protection Against Influenza B Viruses

2024-04-30

Abstract excerpt

Influenza viruses pose a continuing public health challenge due to their high mutation rate and the need for annual vaccine updates. A recent advancement in nanoparticle-based vaccine technology for developing a universal influenza vaccine. We focused on four key studies investigating the use of lipid nanoparticles (LNPs), nanoparticle immunogens, and multivalent epitope-based nanoparticles. The studies demonstrat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dfa718b3-dda0-5c24-b13e-9606650f978f
DOI: 10.20944/preprints202404.1953.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Advances in Nanoparticle-Enhanced Vaccine Strategies: Towards a Universal Protection Against Influenza B VirusesDOI 10.20944/preprints202404.1953.v1Read

Memory B cell Development in Response to mRNA SARS-CoV-2 and Nanoparticle Immunization in MiceSemantic proximity Read

A Universal, Single-Component Multilayered Self-Assembling Protein Nanoparticle Vaccine Based on Extracellular Domains of Matrix Protein 2 Against Both Influenza A and BSemantic proximity Read

An mRNA vaccine candidate encoding H5HA clade 2.3.4.4b protects mice from clade 2.3.2.1a virus infectionSemantic proximity Read

Universal protection against SARS-CoV-2 viruses by multivalent mRNA vaccine in miceSemantic proximity Read

A Single-Component Multilayered Self-Assembling Protein Nanoparticle Vaccine Based on Extracellular Domains of Matrix Protein 2 against Both Influenza A and BSemantic proximity Read

Rational development of a combined mRNA vaccine against COVID-19 and influenzaSemantic proximity Read

A universal TLR7-nanoparticle adjuvant promotes broad immune responses against heterologous strains of Influenza and SARS-CoV-2Semantic proximity Read

Broad heterologous protection against Influenza A viruses by an adjuvant-free modular mucosal T-cell vaccine platformSemantic proximity Read

Polymer-lipid hybrid nanoparticle enhances mRNA delivery and T cell-mediated immunitySemantic proximity Read

Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2Semantic proximity Read

Broad heterologous protection against Influenza A viruses by an adjuvant-free modular mucosal T-cell vaccine platform.Semantic proximity Read

mRNA-Encoded TLR5 Agonist as an Immune AdjuvantSemantic proximity Read